The Internet

Log In or Register



We need to consider whether the participant has the capacity to give consent, whether they are aware of the risks and benefits of participating in the trial and whether they understand what they are consenting to.

The Company's Phase I Clinical Trial Investigates the Safety and Efficacy of Their Product for Juvenile Asthma Sufferers

0 Points

▲ good image

bad image ▼

Ask AI on The Internet

Question: a company conducted a phase I clinical trial and demonstrated the product to be safe and now plans a phase II trial which will involve recruitment of trial participants of the relevant ages who suffer from asthma. Participants are aged 14-20 e)  What factors do we need to consider when determining whether consent is voluntary? [6 marks]

Asked by janagama2

0 Points

Log In or Register to Vote

When determining whether consent is voluntary for a clinical trial involving participants aged 14-20 with asthma, the following factors need to be considered: 1. Informed consent: Ensure that participants are fully aware of the purpose, potential benefits, and risks of the trial, as well as any alternatives to participating in the study. Participants must be provided with comprehensive information in a clear and easily understandable manner. 2. Decision-making capacity: Assess the competence of the participants to make decisions regarding their participation, considering their age, cognitive abilities, and understanding of the study. For participants under the legal age of consent, the consent of a parent or legal guardian may be required in addition to the minor's assent. 3. Absence of coercion: It is crucial to ensure that participants are not coerced or unduly influenced to join the trial. They must not feel pressured by family members, healthcare providers, or study staff to participate in the study. 4. Time for reflection: Allow potential participants ample time to consider the information about the trial, ask questions, and discuss their decision with family members, healthcare providers, or others before deciding to participate in the study. 5. Right to withdraw consent: Emphasize that participation in the study is voluntary, and that participants have the right to withdraw from the study at any time without any negative consequences or impact on their healthcare. 6. Privacy and confidentiality: Ensure that participant's privacy is maintained, and their personal data is protected and used only for the trial's specific purposes. Confidentiality agreements and data security measures should be in place to safeguard participants' information. By considering these factors, researchers can work towards ensuring that consent is genuinely voluntary, allowing for ethical and reliable results from the clinical trial.

Answered by gpt-4

May 22, 2023, 3:23 a.m.

0 Points

Log In or Register to Vote

Think your answer is better than the AI's? Post it below.

Please log in or sign up to post your answer.

This article was generated in part by one of OpenAI’s large-scale language-generation model, answering user janagama2's question. Images were generated with OpenAI's AI model, DALL·E 2. The Internet takes ultimate responsibility for the content of this publication.
If you want your question answered by an AI, click here.

Published: Monday, May 22, 2023

Comment Section



USD